Love story 42 years in the making
I USUALLY do remember important dates in my life but I have to confess that the Johor elections were uppermost in my mind last week and my wife had to remind me that our 42nd anniversary was coming up on Wednesday.
The final four – France, Spain, England, Argentina and road to glory
AFTER 100 games, we are down to the final four of the 2026 World Cup. So far, the conversation has been great on and off the field.
Blockchain: The new backbone of international trade
What comes to your mind when you hear people mentioning the word "blockchain"?
Another wake-up call for Pakatan
The wind that swept through Johor was much stronger than expected, toppling seats held by the Opposition and sending an avalanche of votes to Barisan.
Falling sperm counts a worrying trend worldwide, but end is not near
Men fearing the whole concept of spermageddon often put Dr G on the spot for advice.
The malaise of race politics
Democracy should be about choosing the best candidates to run the country, competent people with integrity. It should not be about narrow ethnic prejudices.
When policy meets Sabah’s reality
Sabahans say the new targeted diesel subsidy scheme overlooks how families, businesses, and long-distance travel work in the country's second-largest state.
Grow beyond labels
Becoming a 'middle power' need not be a rite of passage for smaller nations, even if and when everyone can agree on what it means.
A crucial compass
Constitutional literacy must be a prerequisite for political leadership, says the writer.
How tourism can and should be developed in Malaysia
I am not sure how Tourism Malaysia measures its full key performance indicator (KPI). For an ordinary rakyat Malaysia like me, what I hear is the number of visitors coming into the country every year.
Malaysia can turn drug repurposing into a public-good engine
Countries, health systems, and patients across the Global South face significant challenges in accessing treatment due to high costs, particularly for cancer and rare diseases. Novel targeted cancer therapies can reach RM15,000–20,000 per dose, and personalised gene therapies for rare conditions may exceed several million ringgit. This puts them far beyond what most patients and healthcare systems can afford.
The game doesn’t need conspiracies, it needs consistency
THE past few days have been frustrating to follow as a football fan, to put it mildly.











